WO2002019842A3 - Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung - Google Patents

Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung Download PDF

Info

Publication number
WO2002019842A3
WO2002019842A3 PCT/EP2001/010309 EP0110309W WO0219842A3 WO 2002019842 A3 WO2002019842 A3 WO 2002019842A3 EP 0110309 W EP0110309 W EP 0110309W WO 0219842 A3 WO0219842 A3 WO 0219842A3
Authority
WO
WIPO (PCT)
Prior art keywords
agent
longlasting
produce
retention time
time used
Prior art date
Application number
PCT/EP2001/010309
Other languages
English (en)
French (fr)
Other versions
WO2002019842A2 (de
Inventor
Guenther Beisel
Ruediger Groening
Original Assignee
Guenther Beisel
Ruediger Groening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guenther Beisel, Ruediger Groening filed Critical Guenther Beisel
Priority to AU2002210491A priority Critical patent/AU2002210491A1/en
Priority to JP2002524334A priority patent/JP2004508310A/ja
Priority to EP01978347A priority patent/EP1322182A2/de
Priority to CA002419389A priority patent/CA2419389A1/en
Publication of WO2002019842A2 publication Critical patent/WO2002019842A2/de
Publication of WO2002019842A3 publication Critical patent/WO2002019842A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Mittel zur oralen Einnahme zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung als Zusatzstoff zu Lebensmitteln, zur Herstellung von Nahrungsergänzungsmitteln, Appetitzüglern und/oder Sättigungsmitteln.
PCT/EP2001/010309 2000-09-11 2001-09-07 Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung WO2002019842A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002210491A AU2002210491A1 (en) 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
JP2002524334A JP2004508310A (ja) 2000-09-11 2001-09-07 胃での延長された滞留時間を有する、長時間保持される満腹効果を生じさせるための組成物およびその使用
EP01978347A EP1322182A2 (de) 2000-09-11 2001-09-07 Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung
CA002419389A CA2419389A1 (en) 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10044846.1 2000-09-11
DE10044846A DE10044846A1 (de) 2000-09-11 2000-09-11 Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung

Publications (2)

Publication Number Publication Date
WO2002019842A2 WO2002019842A2 (de) 2002-03-14
WO2002019842A3 true WO2002019842A3 (de) 2007-11-15

Family

ID=7655784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/010309 WO2002019842A2 (de) 2000-09-11 2001-09-07 Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung

Country Status (7)

Country Link
US (1) US20030161885A1 (de)
EP (1) EP1322182A2 (de)
JP (1) JP2004508310A (de)
AU (1) AU2002210491A1 (de)
CA (1) CA2419389A1 (de)
DE (1) DE10044846A1 (de)
WO (1) WO2002019842A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10247910A1 (de) * 2002-10-14 2004-04-22 Beisel, Günther Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes
WO2004056199A1 (de) * 2002-12-19 2004-07-08 Beisel Guenther Zubereitung zur appetitminderung, sättigung und/oder gewichtsreduktion für kinder
EP1572238A1 (de) * 2002-12-19 2005-09-14 Günther Beisel Mittel mit retardierter stofffreisetzung
MX2017001625A (es) * 2014-08-11 2017-07-28 Perora Gmbh Metodo para la induccion de saciedad.
HUE047839T2 (hu) * 2014-08-11 2020-05-28 Perora Gmbh Szemcséket tartalmazó készítmény
US11234935B2 (en) 2015-07-07 2022-02-01 Perora Gmbh Method of inducing satiety
BR112018016824A2 (pt) 2016-02-18 2018-12-26 Perora Gmbh kits compreendendo formulações que induzem saciedade

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3139920A1 (de) * 1981-10-08 1983-04-28 Nittner, Erich, Dr., 8280 Kreuzlingen "mittel in granulatform auf basis von polysaccharid-gummen, verfahren zu seiner herstellung und verwendung"
DE3217071A1 (de) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe
EP0225303A1 (de) * 1985-11-25 1987-06-10 ACO Läkemedel AB Verwendung einer hydrophobischen Substanz zur Herstellung eines darmlöslichen Arzneimittels zur Behandlung von Fettleibigkeit und darmlösliches Präparat
EP0462012A2 (de) * 1990-06-14 1991-12-18 Terumo Kabushiki Kaisha Nahrungsmittel gegen Fettsucht und Verfahren zu seiner Herstellung
WO1998023259A1 (de) * 1996-11-27 1998-06-04 Beisel Guenther Mittel zur erzeugung eines langanhaltenden sättigungseffekts
US6054480A (en) * 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
WO2002000042A2 (en) * 2000-06-26 2002-01-03 The Procter & Gamble Company Compositions and methods for body weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5855917A (en) * 1996-12-04 1999-01-05 Wisconsin Alumni Research Foundation Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3139920A1 (de) * 1981-10-08 1983-04-28 Nittner, Erich, Dr., 8280 Kreuzlingen "mittel in granulatform auf basis von polysaccharid-gummen, verfahren zu seiner herstellung und verwendung"
DE3217071A1 (de) * 1982-05-06 1983-11-10 Rüdiger Dr. 6365 Rosbach Gröning Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe
EP0225303A1 (de) * 1985-11-25 1987-06-10 ACO Läkemedel AB Verwendung einer hydrophobischen Substanz zur Herstellung eines darmlöslichen Arzneimittels zur Behandlung von Fettleibigkeit und darmlösliches Präparat
EP0462012A2 (de) * 1990-06-14 1991-12-18 Terumo Kabushiki Kaisha Nahrungsmittel gegen Fettsucht und Verfahren zu seiner Herstellung
WO1998023259A1 (de) * 1996-11-27 1998-06-04 Beisel Guenther Mittel zur erzeugung eines langanhaltenden sättigungseffekts
US6054480A (en) * 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
WO2002000042A2 (en) * 2000-06-26 2002-01-03 The Procter & Gamble Company Compositions and methods for body weight management

Also Published As

Publication number Publication date
US20030161885A1 (en) 2003-08-28
JP2004508310A (ja) 2004-03-18
CA2419389A1 (en) 2003-02-20
WO2002019842A2 (de) 2002-03-14
DE10044846A1 (de) 2002-04-04
AU2002210491A1 (en) 2002-03-22
EP1322182A2 (de) 2003-07-02

Similar Documents

Publication Publication Date Title
MXPA01007666A (es) Granulos a base de almidon y de lactosa.
MXPA04005887A (es) Composiciones de formula para lactante que comprenden cantidades crecientes de alfa-lactoalbumina.
WO2002046192A3 (en) Thioether substituted imidazoquinolines
CA97597S (en) Stackable tray
WO2004000787A3 (de) Herstellung von cis-pellitorin und verwendung als aromastoff
EP2289492A3 (de) Naltrexonhydrochloridzusammensetzungen
WO2002080850A3 (en) Bulking agents as satiety agents
WO2006081273A8 (en) 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
IL186788A0 (en) Nutritional supplement for hiv patients
WO2002026054A3 (en) Compositions comprising arabinogalactan and a defined protein component
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
WO2004100817A3 (en) Oral care tablet
HUP0402523A2 (hu) Szójatej-kompozíciók és eljárások előállításukra
EP1900802A3 (de) Stückformige Toilettenseifungzusammensetzung ein latentes Säurungsmittel enthaltend
MXPA05012074A (es) Procesos y composiciones para la elaboracion de leche saborizada.
WO2001068645A3 (en) N-cyanomethylcarboxamides and their use as protease inhibitors
DE50200436D1 (de) Nahrungsmittel zur steigerung der kognitiven leistungsfähigkeit
CA2429639A1 (en) Stable azithromycin monohydrate
PL1654419T3 (pl) Kompozycja wodna i jej zastosowanie do wytwarzania papieru
WO2003086272A3 (en) Ultrapure transferrin for pharmaceutical compositions
WO2002019842A3 (de) Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung
MXPA04003499A (es) Utilizacion de cistationina.
WO2001091767A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
JP2004508310A5 (de)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001978347

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2419389

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10363090

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002210491

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002524334

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001978347

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001978347

Country of ref document: EP